SPO Global (SPO Global) ROCE % : 54.46% (As of Sep. 2023)

View and export this data going back to . Start your Free Trial

What is SPO Global ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. SPO Global's annualized ROCE % for the quarter that ended in Sep. 2023 was 54.46%.

SPO Global ROCE % Historical Data

The historical data trend for SPO Global's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SPO Global ROCE % Chart

SPO Global Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

ROCE %

Get a 7-Day Free Trial

SPO Global Quarterly Data
	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep22	Sep23
ROCE %	Get a 7-Day Free Trial															-	-	-	-	54.46

SPO Global ROCE % Calculation

SPO Global's annualized ROCE % for the fiscal year that ended in Dec. 2016 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2016 )		(A: Dec. 2015 )		(A: Dec. 2016 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2016 )		(A: Dec. 2015 )		(A: Dec. 2016 )
	=	-0.178	/	( ( (0.171 - 1.855)	+	(0.054 - 2.302) )	/ 2 )
	=	-0.178	/	( (-1.684	+	-2.248)	/ 2 )
	=	-0.178	/	-1.966
	=	9.05 %

SPO Global's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2023 )		(Q: Sep. 2022 )		(Q: Sep. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2023 )		(Q: Sep. 2022 )		(Q: Sep. 2023 )
	=	3.396	/	( ( (0 - 0)	+	(6.834 - 0.598) )	/ 1 )
	=	3.396	/	( ( 0	+	6.236 )	/ 1 )
	=	3.396	/	6.236
	=	54.46 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

SPO Global (OTCPK:SPOM) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

SPO Global ROCE % Related Terms

Thank you for viewing the detailed overview of SPO Global's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

SPO Global (SPO Global) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » SPO Global Inc (OTCPK:SPOM) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jinan Pharma Valley, 27th Floor Block A J, Shandong, CHN, 33634

Website

http://www.gerpanghealthcare.com

SPO Global Inc is a holding company whose strategic plan is to acquire interests in emerging young businesses and provide financing, advice and guidance to assist them in realizing their potential. The Company is implementing an acquisition roll-up model of acquiring sales, marketing, and manufacturing businesses. The business scope of the company includes bio-pharmaceutical Research and development, development and sales of medical informatization software, medical high-tech introduction, production and sales of medical quality supplies, dietary supplements, and medicine, as well as agents and sales of medical equipment supplies.

Executives

Jeffrey Louis Feuer	officer: Chief Financial Officer	21860 BURBANK BLVD SUITE 380, WOODLAND HILLS CA 91367
Richard H Ryan	officer: Chief Operating Officer	21860 BURBANK BLVD., NORTH BUILDING SUITE 380, WOODLAND HILLS CA 91367
Michael Braunold	director, officer: Chief Executive Officer	C/O AUBIENT CORP, 1033 BECON ST, BROOKLINE MA 02446
Sidney Braun	director	SUITE 404, 6711 MISSISSAUGA ROAD, MISSISSAUGA A6 L5N 2W3
Pauline Dorfman	director	183 REINER ROAD, TORONTO A6 M3H 2L8
Israel Sarussi	10 percent owner, officer: Chief Technology Officer	C/O SPO, SUITE 380, 21860 BURBANK BLVD., WOODLAND HILLS CA 91367